Incidence:  In the United States, it is currently estimated that about 1 –1.3 million people suffer from IBD.  (http://www.cdc.gov/ibd/ibd-epidemiology.htm)  

Approximately 1.6 million Americans currently have IBD, a growth of about 200,000 since the last time CCFA reported this figure (in 2011).  As many as 70,000 new cases of IBD are diagnosed in the United States each year.  There may be as many as 80,000 children in the United States with IBD. (http://www.ccfa.org/assets/pdfs/updatedibdfactbook.pdf)

Medical Cannabis Indication:  Inflammatory Bowel Disease

          Improves:  Inhibits emptying of stomach,

                            Helps food transit through the intestines

                            Alters and improves intestinal mobility

Recommended cannabinoid ratios:  

                     low THC: high CBD (e.g. 1:20)

                     equal ratio THC: CBD (e.g. 1:1) 

                     high THC : low CBD (e.g. 20:1)

Dosing:  

Go slow and start dosing low and titrate until desired results are achieved.

 (Combination of  the above products may be required).  THC doses greater than 10mg/dose not recommended

Other:  

Neuroprotective properties may slow progression of disease.

Cannabinoid replacement therapy may reduce symptoms and prolong survival. 

(Please note that cannabinoid therapy is patient specific and may require dose/concentration adjustment. Please consult with your provider for appropriate therapy options.)

 

References: 

Journal Articles:  

Cannabis for Inflammatory Bowel Disease (Abstract)  

Beneficial effect of the non-psychotropic plant cannabinoid cannabigerol on experimental inflammatory bowel disease (Abstract)  

Marijuana Use Patterns Among Patients with Inflammatory Bowel Disease